South Korea Allergy Diagnostics And Therapeutics Market Size & Outlook
South Korea allergy diagnostics and therapeutics market, 2018-2030 (US$M)
Related Markets
South Korea allergy diagnostics and therapeutics market highlights
- The South Korea allergy diagnostics and therapeutics market generated a revenue of USD 351.6 million in 2023 and is expected to reach USD 632.5 million by 2030.
- The South Korea market is expected to grow at a CAGR of 8.7% from 2024 to 2030.
- In terms of segment, inhaled was the largest revenue generating allergen type in 2023.
- Other Allergens is the most lucrative allergen type segment registering the fastest growth during the forecast period.
Allergy diagnostics and therapeutics market data book summary
| Market revenue in 2023 | USD 351.6 million |
| Market revenue in 2030 | USD 632.5 million |
| Growth rate | 8.7% (CAGR from 2023 to 2030) |
| Largest segment | Inhaled |
| Fastest growing segment | Other Allergens |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Inhaled, Drug, Other Allergens, Food |
| Key market players worldwide | Rohm Co Ltd, Thermo Fisher Scientific Inc, PerkinElmer, BioMerieux SA, Siemens Healthineers AG ADR, Omega Healthcare Investors Inc, Danaher Corp, Alcon Inc, AbbVie Inc, Sanofi SA, Allergy Therapeutics PLC, Pfizer Inc, Teva Pharmaceutical Industries Ltd, GSK PLC, Sun Pharmaceutical Industries, Roche Holding AG, Merck & Co Inc, Astellas Pharma Inc, Epigenomics AG |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.1% of the global allergy diagnostics and therapeutics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan allergy diagnostics and therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 683.8 million by 2030.
Inhaled was the largest segment with a revenue share of 55.06% in 2023. Horizon Databook has segmented the South Korea allergy diagnostics and therapeutics market based on inhaled, drug, other allergens, food covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea’s allergy diagnostic and therapeutic market growth can be attributed to introduction of diagnostic and therapeutic products with advanced technologies, which offer high sensitivity, efficacy, and accuracy. Rising prevalence of allergic diseases along with high demand for in vitro diagnostic blood tests is further estimated to drive the industry growth in the coming years.
Moreover, various factors, such as increasing indoor and outdoor pollution, changing lifestyle, unhealthy dietary habits, and rapid industrialization & urbanization are projected to result in increased cases of allergic conditions and are estimated to positively impact the market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Allergy Diagnostics And Therapeutics Market Scope
Allergy Diagnostics And Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea allergy diagnostics and therapeutics market size, by allergen type, 2018-2030 (US$M)
South Korea Allergy Diagnostics And Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
